Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 7Hodgkin Disease 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell 4Glioblastoma 4Lymphoma, T-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Gliosarcoma 3Glioma 3Burkitt Lymphoma 3Multiple Myeloma 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Prolymphocytic, T-Cell 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vasculitis, Central Nervous System 1Stiff-Person Syndrome 1Sezary Syndrome 1Rasmussen subacute encephalitis 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Plasmablastic Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Opsoclonus-Myoclonus Syndrome 1Neuromyelitis Optica 1Neoplasms, Plasma Cell 1

Interventions

Temozolomide 162Radiosurgery 115Radiotherapy 100Bevacizumab 96Magnetic Resonance Spectroscopy 65Carboplatin 48Etoposide 34pembrolizumab 33Surgical Procedures, Operative 33Irinotecan 33Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 30Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × carmustine, poliferprosan 20 drug combination × Clear all
NCT04222062 2026-04-28

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

University of Nebraska

Phase 2 Recruiting
100 enrolled
CNS

Brain Neoplasms

NCT00525590 2020-03-16

Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

Eisai Inc.

Phase 2 Completed
69 enrolled 17 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡